Acquisitions in Navarre, Spain

CVC funds have acquired the entire stake in Grupo Monbake from Ardian and its co-investors Alantra, Artá and Landon. The private markets manager will partner with Monbake's existing management to drive global expansion and strengthen the group's innovation and production capabilities in the frozen dough and bakery sector. Transaction financial terms were not disclosed.

Biovian and 3P Biopharmaceuticals have combined under their common shareholder Keensight Capital to form 3PBIOVIAN, a pan‑European biologics CDMO offering end‑to‑end development and manufacturing across microbial and mammalian protein expression, viral vectors, cell therapy and plasmid DNA. The combined group will operate sites in Pamplona‑Noáin (Spain) and Turku (Finland), maintain a commercial office in Boston, and employ over 500 professionals with gross sales above €75m; ERES IV (advised by Elyan Partners) and Sodena will remain minority shareholders alongside Keensight.

Ardena, a GHO Capital-backed specialist pharmaceutical CDMO, has acquired Idifarma from Suanfarma and Sodena. The deal expands Ardena's European footprint and adds Idifarma's spray drying technology and high-potency drug capabilities at its Pamplona site, supporting Ardena's integrated end-to-end CDMO strategy.

Aurica Capital has taken a 41.5% minority stake in STI Norland through its Aurica III fund, providing growth capital to the Pamplona-based manufacturer of large-scale photovoltaic trackers and mounting structures. The investment will support STI Norland's international expansion and continued product and service development; financial terms were not disclosed.